Galera reels in $150M to test radiation side effect drug in phase 3 |…
Galera Therapeutics has raised $150 million that will bring a drug designed to ward off inflammatory side effects from radiation therapy into a pivotal phase…
Browsing Tag
drug
Viking Therapeutics’ fatty liver drug cuts cholesterol in phase 2 | Digital…
Viking Therapeutics’ lead lipid disorder asset met its primary and secondary endpoints in a midstage trial, dropping cholesterol and liver fat levels in…
Is predictive maintenance the ‘gateway drug’ to the Industrial IoT? |…
I’ve said it before, but it bears repeating: When it comes to the Internet of Things (IoT), the consumer market gets all the attention, but the real action may…
VistaGen nabs phase 3-ready social anxiety drug from Pherin | Digital…
VistaGen Therapeutics has licensed Pherin Pharmaceuticals’ lead candidate, a phase 3-ready treatment for social anxiety disorder (SAD). Under the deal,…
Dealers remain on Instagram as it pushes drug searchers to treatment |…
You don’t have to search too hard to find Xanax and Fentanyl dealers posting their phone numbers all over Instagram, but at least it’s starting to push people…
Dealers remain on Instagram as it pushes drug searchers to treatment | Apps…
Latest Apps and Software News
You don’t have to search too hard to find Xanax and Fentanyl dealers posting their phone numbers all over Instagram, but at…
The body count of mayors in the Philippines is going up as Duterte’s drug…
Digital Asia News Update
caption Protesters light candles and shout slogans as they march on the street on September 8, 2017 in Quezon City, Philippines.…
Machine learning predicts metabolism, helping drug developers and brewers |…
Cerevisiae cells in DIC microscopy. Credit: public domain
Machine learning algorithms that can predict yeast metabolism from its protein content have been…
EyeGate’s anti-inflammatory eye drug and electric delivery device fail…
EyeGate Pharmaceuticals’ corticosteroid treatment for noninfectious anterior uveitis—delivered directly into the ocular tissue via the company’s device and a…
Another setback for AstraZeneca as lupus drug fails phase 3 test | Digital…
Despite encouraging midstage data for AstraZeneca’s drug for systemic lupus erythematosus (SLE), anifrolumab has missed the target in the first of two ongoing…